부인과용 기기 시장 : 제품별, 최종 용도별 - 세계 예측(2024-2032년)

Gynecological devices market size is poised to witness 8.1% CAGR between 2024 and 2032 driven by the increasing prevalence of gynecological disorders and diseases. Conditions, such as endometriosis, polycystic ovary syndrome (PCOS), and cervical cancer are becoming more common, further prompting the higher demand for diagnostic and therapeutic devices. As per reports, 1 in every 10 women suffer from PCOS.

Technological advancements, such as the development of minimally invasive procedures and sophisticated imaging techniques, are also contributing to the market growth. Health initiatives and educational programs are emphasizing the importance of regular gynecological check-ups and early detection for seeking medical attention and utilizing advanced gynecological devices. The rising adoption of digital health technologies and telemedicine has also expanded access to gynecological care, further boosting the product demand.

The gynecological devices industry is classified into product, end-use, and region.

Based on product, the market size from the diagnostic imaging systems segment is anticipated to witness growth through 2032 due to its critical role in the early detection and precise diagnosis of gynecological conditions. Advanced imaging technologies, such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) are enabling the detailed visualization of the reproductive organs for facilitating accurate assessments of disorders like ovarian cysts, fibroids, and cancers.

In terms of end-use, the gynecological devices industry from the ambulatory surgical centers segment is predicted to record notable gains up to 2032. This is owing to the rising preference for outpatient surgical procedures to offer convenience and cost-effectiveness. Ambulatory surgical centers (ASCs) further specialize in providing same-day surgical care, including minimally invasive gynecological procedures to reduce the need for hospital admissions and lower the overall healthcare costs.

Asia Pacific gynecological devices market size will grow significantly through 2032 attributed to the increasing investments in healthcare infrastructure and the expansion of healthcare services. Governments and private entities in the region are enhancing their healthcare facilities, particularly in emerging economies like India and China to improve access to advanced gynecological care. The rising disposable incomes and the growing healthcare awareness among the population are also leading to higher demand for specialized gynecological treatments and devices, adding to the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of gynecological disorders
    • 3.2.1.2 Increase in initiatives promoting routine checkup
    • 3.2.1.3 Introduction of technically advanced products
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Increase in adoption of alternate therapies
• 3.3 Growth potential analysis
• 3.4 Reimbursement scenario
• 3.5 Regulatory landscape
• 3.6 Technological landscape
  • 3.6.1 Core technologies
  • 3.6.2 Adjacent technologies
• 3.7 Future market trends
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Surgical devices
  • 5.2.1 Gynecological endoscopy devices
    • 5.2.1.1 Hysteroscope
    • 5.2.1.2 Colposcope
    • 5.2.1.3 Resectoscope
    • 5.2.1.4 Laparoscope
    • 5.2.1.5 Endoscope imaging systems
  • 5.2.2 Endometrial ablation devices
    • 5.2.2.1 Hydrothermal ablation devices
    • 5.2.2.2 Radiofrequency ablation devices
    • 5.2.2.3 Balloon ablation devices
    • 5.2.2.4 Other endometrial ablation devices
  • 5.2.3 Fluid management systems
  • 5.2.4 Female sterilization/contraceptive devices
    • 5.2.4.1 Permanent birth control
    • 5.2.4.2 Intra uterine devices (IUD)
    • 5.2.4.3 Intravaginal rings
    • 5.2.4.4 Subdermal contraceptive implants
• 5.3 Handheld instruments
  • 5.3.1 Vaginal speculum
  • 5.3.2 Tenaculum
  • 5.3.3 Curettes
  • 5.3.4 Trocars
  • 5.3.5 Biopsy forceps
  • 5.3.6 Other handheld instruments
• 5.4 Diagnostic imaging systems

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Hospital and clinics
• 6.3 Ambulatory surgery centers
• 6.4 Diagnostic centers
• 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
  • 7.3.7 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

• 8.1 Abbott Laboratories
• 8.2 Bayer AG
• 8.3 Boston Scientific Corporation
• 8.4 CooperSurgical, Inc.
• 8.5 Fresenius Medical Care AG & Co. KGaA
• 8.6 Hologic, Inc.
• 8.7 Intuitive Surgical, Inc.
• 8.8 Johnson & Johnson (Ethicon, Inc.)
• 8.9 Karl Storz SE & Co. KG
• 8.10 Medtronic plc
• 8.11 Olympus Corporation
• 8.12 Richard Wolf GmbH
• 8.13 Smith & Nephew plc
• 8.14 Stryker Corporation
• 8.15 Zimmer Biomet Holdings, Inc.